Latest Adalimumab Stories
An advisory panel recommends that the FDA consider approving Pfizer’s pill to treat rheumatoid arthritis. The pill, tofacitinib, would be sold to patients who don’t respond to traditional rheumatoid arthritis treatments.
Tokyo, Apr 23, 2012 - (JCN Newswire) - Abbott Japan Co., Ltd. and Eisai Co., Ltd.
The American College of Rheumatology (ACR) has released the 2012 recommendations for the use of disease-modifying antirheumatic drugs (DMARDs) and biologic agents in the treatment of rheumatoid arthritis (RA).
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary.
- A woman chauffeur.
- A woman who operates an automobile.